Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Popik

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Polish Journal of Pharmacology and Pharmacy|May 1, 1987
Stability and variability of locomotor responses of laboratory rodents. II. Native exploratory and basal locomotor activity of Wistar ratsJ Vetulani, D Marona-Lewicka, J Michaluk, et al.
Neuropharmacology|December 2, 1998
Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonistsP Popik, J Mamczarz, M Fraczek, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 25, 2006
Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension testsI V Belozertseva, T Kos, P Popik, et al.
European Journal of Pharmacology|November 30, 1995
[3H]1-aminocyclopropanecarboxylic acid, a novel probe for strychnine- insensitive glycine receptorsP Popik, A Lewin, B Berrang, et al.
Neuropharmacology|December 23, 1999
Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal modelsA Kłodzińska, E Chojnacka-Wójcik, A Pałucha, et al.
Pharmacopsychiatry|January 1, 1996
Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depressionP Skolnick, R T Layer, P Popik, et al.
European Journal of Pharmacology|September 22, 1994
Adenosine A3 receptor stimulation and cerebral ischemiaD K Von Lubitz, R C Lin, P Popik, et al.
British Journal of Pharmacology|August 16, 2015
Pro-cognitive activity in rats of 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptorA Potasiewicz, T Kos, F Ravazzini, et al.
European Journal of Pharmacology|August 8, 1996
Structurally modified ibogaine analogs exhibit differing affinities for NMDA receptorsR T Layer, P Skolnick, C M Bertha, et al.
Psychopharmacology|August 21, 2001
The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humansA Bisaga, S D Comer, A S Ward, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Polish Journal of Pharmacology and Pharmacy|May 1, 1987
Stability and variability of locomotor responses of laboratory rodents. II. Native exploratory and basal locomotor activity of Wistar ratsJ Vetulani, D Marona-Lewicka, J Michaluk, et al.
Neuropharmacology|December 2, 1998
Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonistsP Popik, J Mamczarz, M Fraczek, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 25, 2006
Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension testsI V Belozertseva, T Kos, P Popik, et al.
European Journal of Pharmacology|November 30, 1995
[3H]1-aminocyclopropanecarboxylic acid, a novel probe for strychnine- insensitive glycine receptorsP Popik, A Lewin, B Berrang, et al.
Neuropharmacology|December 23, 1999
Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal modelsA Kłodzińska, E Chojnacka-Wójcik, A Pałucha, et al.
Pharmacopsychiatry|January 1, 1996
Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depressionP Skolnick, R T Layer, P Popik, et al.
European Journal of Pharmacology|September 22, 1994
Adenosine A3 receptor stimulation and cerebral ischemiaD K Von Lubitz, R C Lin, P Popik, et al.
British Journal of Pharmacology|August 16, 2015
Pro-cognitive activity in rats of 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptorA Potasiewicz, T Kos, F Ravazzini, et al.
European Journal of Pharmacology|August 8, 1996
Structurally modified ibogaine analogs exhibit differing affinities for NMDA receptorsR T Layer, P Skolnick, C M Bertha, et al.
Psychopharmacology|August 21, 2001
The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humansA Bisaga, S D Comer, A S Ward, et al.
Pageof 7